TickerGuard
Buy Day today: Neutral (51) Mixed market breadth · no major macro event
ARVN

Arvinas Inc

Healthcare · Biotechnology

8.30$ -0.2% vs. previous close Closing price · As of: Sep 18, 2026

Statements

Income Statement

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Income Statement ARVN
Line item 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
+13.6% +89.0% +200.0% -49.3% +114.2% +181.4% -40.3% +235.5% -0.3%
+39.8% -100.0% +36.7% -18.3% -1.5% -21.2%
+13.6% +89.0% +200.0% -49.3% +114.2% +181.4% -40.3% +235.5% -2.3%
+44.4% +57.0% +48.7% +61.3% +66.5% +74.6% +20.5% -8.3% -18.8%
+11.0% +264.7% +111.2% +40.3% +60.8% +29.2% +26.0% +64.9% -45.9%
+39.8% +79.7% +62.6% +55.2% +65.0% +63.1% +21.6% +7.0% -27.5%
-25.3% +14.1% +49.0% -24.0% +53.8% +11,900.0%
+293.5% -443.0% -95.7% -33.3% -50.0%

Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?